We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMC
1226
Summit Midstream
SMC
$419M
$22K ﹤0.01%
+302
New +$27.7K
MOR
1227
DELISTED
MorphoSys AG American Depositary Shares
MOR
$22K ﹤0.01%
+787
New +$22.6K
VET icon
1228
Vermilion Energy
VET
$1.66B
$21K ﹤0.01%
+1,263
New +$21.9K
PDCE
1229
DELISTED
PDC Energy, Inc.
PDCE
$21K ﹤0.01%
761
-46,696
-98% -$1.4M
BXG
1230
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$21K ﹤0.01%
+2,279
New +$23.1K
FISI icon
1231
Financial Institutions
FISI
$821M
$20K ﹤0.01%
+666
New +$19.5K
WRB icon
1232
W.R. Berkley
WRB
$26.6B
$20K ﹤0.01%
+626
New +$19.6K
CEMI
1233
DELISTED
Chembio diagnostics, Inc.
CEMI
$20K ﹤0.01%
+3,224
New +$19.2K
CPA icon
1234
Copa Holdings
CPA
$5.8B
$19K ﹤0.01%
+195
New +$19.6K
SJM icon
1235
J.M. Smucker
SJM
$12.8B
$18K ﹤0.01%
168
-1,641
-91% -$183K
LBY
1236
DELISTED
Libbey, Inc.
LBY
$18K ﹤0.01%
+5,289
New +$10.3K
VSI
1237
DELISTED
Vitamin Shoppe Inc.
VSI
$18K ﹤0.01%
+2,784
New +$15.6K
BLUE
1238
DELISTED
bluebird bio
BLUE
$17K ﹤0.01%
+15
New +$22.9K
WHG icon
1239
Westwood Holdings Group
WHG
$190M
$17K ﹤0.01%
+604
New +$18.4K
TXNM
1240
TXNM Energy Inc
TXNM
$5.94B
$17K ﹤0.01%
+319
New +$16.1K
VEEV icon
1241
Veeva Systems
VEEV
$37.4B
$16K ﹤0.01%
102
-9,565
-99% -$1.53M
CPLG
1242
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$16K ﹤0.01%
+1,538
New +$16.6K
CHCT
1243
Community Healthcare Trust
CHCT
$454M
$15K ﹤0.01%
+336
New +$14.2K
KBAL
1244
DELISTED
Kimball International
KBAL
$15K ﹤0.01%
+759
New +$13.6K
OTLKW
1245
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$15K ﹤0.01%
125,400
– –
AMRS
1246
DELISTED
Amyris Inc.
AMRS
$14K ﹤0.01%
+2,981
New +$11.1K
WBC
1247
DELISTED
WABCO HOLDINGS INC.
WBC
$14K ﹤0.01%
+102
New +$13.6K
EMMA
1248
DELISTED
Emmaus Life Sciences, Inc. Common Stock
EMMA
$14K ﹤0.01%
+6,008
New +$33K
DAVA icon
1249
Endava
DAVA
$156M
$13K ﹤0.01%
+333
New +$12.8K
M icon
1250
Macy's
M
$6.68B
$13K ﹤0.01%
844
-260,502
-100% -$4.82M
48 49
50
51 52

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.